SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 375 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,693 | +5.5% | 96,465 | -0.3% | 0.03% | +8.3% |
Q2 2023 | $11,085 | -13.0% | 96,791 | +4.7% | 0.02% | -17.2% |
Q1 2023 | $12,740 | +5909.4% | 92,434 | +5556.9% | 0.03% | +2800.0% |
Q4 2022 | $212 | -99.8% | 1,634 | +41.6% | 0.00% | – |
Q3 2022 | $128,000 | -93.4% | 1,154 | -95.6% | 0.00% | -100.0% |
Q1 2021 | $1,953,000 | -88.1% | 26,209 | -72.8% | 0.01% | -89.6% |
Q4 2020 | $16,424,000 | -37.7% | 96,335 | -48.7% | 0.05% | +14.3% |
Q3 2020 | $26,372,000 | -22.5% | 187,792 | -11.6% | 0.04% | -28.8% |
Q2 2020 | $34,044,000 | +352.4% | 212,328 | +176.0% | 0.06% | +55.3% |
Q1 2020 | $7,526,000 | -41.7% | 76,934 | -23.1% | 0.04% | -24.0% |
Q4 2019 | $12,909,000 | +69.1% | 100,038 | -1.3% | 0.05% | +38.9% |
Q3 2019 | $7,634,000 | -47.9% | 101,352 | +5.1% | 0.04% | -49.3% |
Q2 2019 | $14,654,000 | -1.8% | 96,440 | -23.0% | 0.07% | -2.7% |
Q1 2019 | $14,927,000 | +10.0% | 125,235 | +0.7% | 0.07% | +7.4% |
Q4 2018 | $13,568,000 | -22.6% | 124,325 | +14.5% | 0.07% | -20.9% |
Q3 2018 | $17,534,000 | – | 108,562 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
IMS Capital Management | 32,215 | $774,000 | 0.91% |
Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |